108 related articles for article (PubMed ID: 11876527)
1. Protease nexin-1 messenger RNA levels are not affected by serum or interferon beta in cultured systemic sclerosis fibroblasts.
de Oliveira JG; Guedes AC; Lanna CC; Coelho LF; Prados RZ; Feghali C; Ferreira PC; Kroon EG
Arch Dermatol Res; 2002 Jan; 293(11):584-9. PubMed ID: 11876527
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
3. A potential role for protease nexin 1 overexpression in the pathogenesis of scleroderma.
Strehlow D; Jelaska A; Strehlow K; Korn JH
J Clin Invest; 1999 Apr; 103(8):1179-90. PubMed ID: 10207170
[TBL] [Abstract][Full Text] [Related]
4. Protease nexin-1, a thrombin inhibitor, is regulated by interleukin-1 and dexamethasone in normal human fibroblasts.
Guttridge DC; Lau AL; Cunningham DD
J Biol Chem; 1993 Sep; 268(25):18966-74. PubMed ID: 8360185
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of 2'5'oligoadenylate synthetase and double-stranded RNA dependent protein kinase messenger RNAs on affected skin of systemic sclerosis patients.
Coelho LF; de Oliveira JG; de Oliveira DB; Guedes AC; Lanna CC; Prados RZ; Ferreira PC; Bonjardim CA; Kroon EG
Arch Dermatol Res; 2007 Aug; 299(5-6):259-62. PubMed ID: 17541615
[TBL] [Abstract][Full Text] [Related]
6. Serum levels, tissue expression and cellular secretion of macrophage migration inhibitory factor in limited and diffuse systemic sclerosis.
Corallo C; Paulesu L; Cutolo M; Ietta F; Carotenuto C; Mannelli C; Romagnoli R; Nuti R; Giordano N
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S98-105. PubMed ID: 26005773
[TBL] [Abstract][Full Text] [Related]
7. Progranulin Overproduction Due to Fli-1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic Sclerosis.
Ichimura Y; Asano Y; Akamata K; Noda S; Taniguchi T; Takahashi T; Toyama T; Tada Y; Sugaya M; Sato S; Kadono T
Arthritis Rheumatol; 2015 Dec; 67(12):3245-55. PubMed ID: 26245842
[TBL] [Abstract][Full Text] [Related]
8. Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts.
Ihn H; Yamane K; Asano Y; Jinnin M; Tamaki K
Rheumatology (Oxford); 2006 Feb; 45(2):157-65. PubMed ID: 16319104
[TBL] [Abstract][Full Text] [Related]
9. Increased accumulation of extracellular thrombospondin-2 due to low degradation activity stimulates type I collagen expression in scleroderma fibroblasts.
Kajihara I; Jinnin M; Yamane K; Makino T; Honda N; Igata T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
Am J Pathol; 2012 Feb; 180(2):703-14. PubMed ID: 22142808
[TBL] [Abstract][Full Text] [Related]
10. A reactive oxygen species-mediated loop maintains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis.
Spadoni T; Svegliati Baroni S; Amico D; Albani L; Moroncini G; Avvedimento EV; Gabrielli A
Arthritis Rheumatol; 2015 Jun; 67(6):1611-22. PubMed ID: 25707572
[TBL] [Abstract][Full Text] [Related]
11. Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts.
Ichiki Y; Smith EA; LeRoy EC; Trojanowska M
J Rheumatol; 1997 Jan; 24(1):90-5. PubMed ID: 9002017
[TBL] [Abstract][Full Text] [Related]
12. A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis.
Yamashita T; Asano Y; Taniguchi T; Nakamura K; Saigusa R; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
Exp Dermatol; 2016 Apr; 25(4):287-92. PubMed ID: 26661692
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of heat-shock protein 47 is associated with overproduction of type I procollagen in systemic sclerosis skin fibroblasts.
Kuroda K; Tsukifuji R; Shinkai H
J Invest Dermatol; 1998 Dec; 111(6):1023-8. PubMed ID: 9856811
[TBL] [Abstract][Full Text] [Related]
14. A novel protein highly expressed in testis is overexpressed in systemic sclerosis fibroblasts and targeted by autoantibodies.
Yasuoka H; Ihn H; Medsger TA; Hirakata M; Kawakami Y; Ikeda Y; Kuwana M
J Immunol; 2003 Dec; 171(12):6883-90. PubMed ID: 14662895
[TBL] [Abstract][Full Text] [Related]
15. Increased transcriptional activities of transforming growth factor beta receptors in scleroderma fibroblasts.
Yamane K; Ihn H; Kubo M; Tamaki K
Arthritis Rheum; 2002 Sep; 46(9):2421-8. PubMed ID: 12355490
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis.
Distler O; Pap T; Kowal-Bielecka O; Meyringer R; Guiducci S; Landthaler M; Schölmerich J; Michel BA; Gay RE; Matucci-Cerinic M; Gay S; Müller-Ladner U
Arthritis Rheum; 2001 Nov; 44(11):2665-78. PubMed ID: 11710722
[TBL] [Abstract][Full Text] [Related]
17. Increased interleukin 1 receptor, type I, at messenger RNA and protein level in skin fibroblasts from patients with systemic sclerosis.
Kawaguchi Y; Harigai M; Hara M; Suzuki K; Kawakami M; Ishizuka T; Hidaka T; Kitani A; Kawagoe M; Nakamura H
Biochem Biophys Res Commun; 1992 May; 184(3):1504-10. PubMed ID: 1375465
[TBL] [Abstract][Full Text] [Related]
18. Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis.
Dees C; Tomcik M; Zerr P; Akhmetshina A; Horn A; Palumbo K; Beyer C; Zwerina J; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2011 Jul; 70(7):1304-10. PubMed ID: 21450749
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of ephrins and thrombospondins in the dermis of patients with early diffuse systemic sclerosis: potential contribution to perturbed angiogenesis and fibrosis.
Avouac J; Clemessy M; Distler JH; Gasc JM; Ruiz B; Vacher-Lavenu MC; Wipff J; Kahan A; Boileau C; Corvol P; Allanore Y
Rheumatology (Oxford); 2011 Aug; 50(8):1494-504. PubMed ID: 21454305
[TBL] [Abstract][Full Text] [Related]
20. The Histone Deacetylase Sirtuin 1 Is Reduced in Systemic Sclerosis and Abrogates Fibrotic Responses by Targeting Transforming Growth Factor β Signaling.
Wei J; Ghosh AK; Chu H; Fang F; Hinchcliff ME; Wang J; Marangoni RG; Varga J
Arthritis Rheumatol; 2015 May; 67(5):1323-34. PubMed ID: 25707573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
